FDA reverses course and will review Moderna’s mRNA flu shot, company says

  • Posted on February 18, 2026
  • By Bing News
  • 1 Views
FDA reverses course and will review Moderna’s mRNA flu shot, company says

The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday,
continue reading...

Author
Bing News

You May Also Like